Ekso Bionics Holdings, Inc. Announces Resignation of William Shaw as Chief Commercial Officer, Effective on March 11, 2022
March 10, 2022 at 04:15 pm EST
Share
On March 4, 2022, William Shaw, the Chief Commercial Officer of Ekso Bionics Holdings, Inc. notified the Board of Directors of his intention to resign as Chief Commercial Officer of the company effective March 11, 2022 in connection with his retention as an employee at another company.
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
EKSO BIONICS HOLDINGS, INC. 
